|
Name |
2,6,11-Trimethyldodecane
|
Molecular Formula | C15H32 | |
IUPAC Name* |
2,6,11-trimethyldodecane
|
|
SMILES |
CC(C)CCCCC(C)CCCC(C)C
|
|
InChI |
InChI=1S/C15H32/c1-13(2)9-6-7-11-15(5)12-8-10-14(3)4/h13-15H,6-12H2,1-5H3
|
|
InChIKey |
FONXOARHSFUBAN-UHFFFAOYSA-N
|
|
Synonyms |
2,6,11-TRIMETHYLDODECANE; 31295-56-4; Dodecane, 2,6,11-trimethyl-; DTXSID60865591; CHEBI:132283; 4-Methyl-2-pyrimidinecarboxylicacid; 2,6,11-TETRAMETHYLDODECANE; LMFA11000682; FT-0729382
|
|
CAS | 31295-56-4 | |
PubChem CID | 35768 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 212.41 | ALogp: | 7.5 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 15 | QED Weighted: | 0.423 |
Caco-2 Permeability: | -4.382 | MDCK Permeability: | 0.00001030 |
Pgp-inhibitor: | 0.009 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.283 |
30% Bioavailability (F30%): | 0.911 |
Blood-Brain-Barrier Penetration (BBB): | 0.396 | Plasma Protein Binding (PPB): | 97.84% |
Volume Distribution (VD): | 2.711 | Fu: | 2.42% |
CYP1A2-inhibitor: | 0.321 | CYP1A2-substrate: | 0.204 |
CYP2C19-inhibitor: | 0.44 | CYP2C19-substrate: | 0.765 |
CYP2C9-inhibitor: | 0.479 | CYP2C9-substrate: | 0.958 |
CYP2D6-inhibitor: | 0.032 | CYP2D6-substrate: | 0.032 |
CYP3A4-inhibitor: | 0.122 | CYP3A4-substrate: | 0.138 |
Clearance (CL): | 6.736 | Half-life (T1/2): | 0.071 |
hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.021 |
Drug-inuced Liver Injury (DILI): | 0.253 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.028 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.856 | Carcinogencity: | 0.045 |
Eye Corrosion: | 0.99 | Eye Irritation: | 0.974 |
Respiratory Toxicity: | 0.186 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000536 | 0.702 | D00FSV | 0.351 | ||||
ENC000806 | 0.702 | D0D9NY | 0.226 | ||||
ENC001120 | 0.674 | D03LGY | 0.224 | ||||
ENC000537 | 0.660 | D05QNO | 0.205 | ||||
ENC000766 | 0.654 | D0I8CA | 0.202 | ||||
ENC000538 | 0.648 | D0K5WS | 0.192 | ||||
ENC000902 | 0.627 | D0ZI4H | 0.190 | ||||
ENC000627 | 0.617 | D0T9TJ | 0.190 | ||||
ENC000441 | 0.593 | D0N3NO | 0.188 | ||||
ENC000815 | 0.571 | D0G2KD | 0.186 |